Rudy Murgo - Feb 13, 2023 Form 4/A - Amendment Insider Report for NUSCALE POWER Corp (SMR)

Role
Treasurer
Signature
Patrick C. Cannon, attorney-in-fact for Rudolph Murgo
Stock symbol
SMR
Transactions as of
Feb 13, 2023
Transactions value $
$142,476
Form type
4/A - Amendment
Date filed
2/23/2023, 02:37 PM
Date Of Original Report
Feb 15, 2023
Previous filing
Jul 11, 2022
Next filing
Feb 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMR Class A Common Stock Options Exercise $78.6K +12.3K +157.42% $6.41 20.1K Feb 13, 2023 Direct F1
transaction SMR Class A Common Stock Options Exercise $37K +5.77K +28.77% $6.41 25.8K Feb 13, 2023 Direct F1
transaction SMR Class A Common Stock Options Exercise $26.8K +2.82K +55.86% $9.53 7.85K Feb 13, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMR Employee Stock Option (right to buy) Options Exercise $0 -12.3K -70.84% $0.00 5.05K Feb 13, 2023 Class A Common Stock 12.3K $6.41 Direct F2, F3
transaction SMR Employee Stock Option (right to buy) Options Exercise $0 -5.77K -33.33% $0.00 11.5K Feb 13, 2023 Class A Common Stock 5.77K $6.41 Direct F2, F4
transaction SMR Employee Stock Option (right to buy) Options Exercise $0 -2.82K -27.09% $0.00 7.58K Feb 13, 2023 Class A Common Stock 2.82K $9.53 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of Acquired Securities and Amount of Securities Beneficially Owned following the transaction were inaccurately reported on Form 4 filed February 15, 2023.
F2 The Number of Derivatives Disposed of and Number of Derivative Securities Beneficially owned following reported transaction were inaccurately reported on Form 4 filed February 15, 2022.
F3 The option became exercisable for 25% of the shares on April 1, 2021, and for 1/48th of the shares at the end of each one-month period thereafter, so that the option will become fully exercisable on April 1, 2024.
F4 The option became exercisable for 25% of the shares on November 1, 2022, and for 1/48th of the shares at the end of each one-month period thereafter, so that the option will become fully exercisable on November 1, 2025.
F5 The option became exercisable for 25% of the shares on January 4, 2023, and for 1/48th of the shares at the end of each one-month period thereafter, so that the option will become fully exercisable on January 4, 2026.